Utilization and costs associated with compound medications fell significantly for both managed and unmanaged claims in 2017.
Overall opioid cost and utilization continue to drop, due in part to market, societal, and regulatory influences, and the trend is expected to continu
Regulars at Costco know the Kirkland name well.
Therapeutic classes falling within the top 10 most utilized and costly categories had some interesting, although not altogether unsurprising, movement